---
title: "#PHARMA: Want to invest in the new Berkshire Hathaway for Health Care?"
publisher: "Share Talk"
author: "sharetalk"
published: "2017-11-28T10:54:02+00:00"
modified: "2017-11-28T10:54:02+00:00"
date: 2017-11-28
canonical: "https://www.share-talk.com/pharma-want-to-invest-in-the-new-berkshire-hathaway-for-health-care/"
category: "Learning and Investing"
categories: ["Learning and Investing"]
image: "https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1"
format: "news"
language: "en-GB"
---

# #PHARMA: Want to invest in the new Berkshire Hathaway for Health Care?

**Published:** November 28, 2017
**Author:** sharetalk
**Categories:** Learning and Investing
**Featured image:** ![](https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1)

---

Peter Garcia, the CFO at PDL BioPharma explains that in his view, PDL is ‘unique’. Located in Lake Tahoe, Nevada,  PDL is a publicly traded private equity group listed on Nasdaq: #PDLI.

‘PDL allows investors to derisk and invest in a portfolio of products and companies’ says Mr Garcia. ‘We recently bought a company and bought a drug to put into that company. We don’t do research and development ourselves. We acquire income streams’.

PDL BioPharma seeks to provide a significant return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries.

This interview is one of a series with Edison pharma clients shot at the Biotech and Money Conference at the Waldorf Hotel, London on 14.11.2017.

---

**Original URL:** https://www.share-talk.com/pharma-want-to-invest-in-the-new-berkshire-hathaway-for-health-care/
*Created by [WP Markdown Endpoint](https://wpmarkdownendpoint.com/)*